India Remdesivir market is
anticipated to grow with an impressive CAGR in the forecast period,
FY2023-FY2027. The market has shown a consistent growth in the last five years
and it is expected to grow with the projected cumulative annular growth rate on
the account of increasing prevalence of COVID-19 patients and the surge in the
demand of drugs to overcome the viral infection. Moreover, the chronic diseases
are rapidly increasing in the country, with changing lifestyle and the life
choice of the population, the Remdesivir market in India is expected to grow in
the upcoming five years. Also, India has a large number of geriatric populations,
that is more prone to infectious diseases which in turn, is influencing the
growth of India Remdesivir market growth, positively.
Remdesivir is an antiviral
medication that is developed by the biopharmaceutical company Gilead Sciences. Administered
via injection into a vein, the drug manufacturing process started in March 2020
with a research performed by Gilead Sciences Inc. The research was performed on
53 prospective COVID-19 patients out of which only 36 patients showed signs of
progress that accounted for about 68% of the total number of patients. World Health
Organization has guided the start of clinical trials for the drug along with
three other drugs found to be effective in COVID-19 therapy. Remdesivir drug
has reached phase 3 of clinical trials and the world hopes it will emerge as a
promising treatment for COVID-19. Following these positive trials, the food and
drug administration issued permission for the medication to treat Covid-19 for
emergency use authorization (EUA). That means the medication has not undergone
the same examination as therapies approved by the FDA, but it will allow
doctors to prescribe Remdesivir to patients hospitalized with the disease. All
supply of drugs will go to the government for allocation across the nation.
India Remdesivir market segmentations
is based on application,
route of administration, dosage form, patient age, distribution channel,
and regional distribution. Based on application, the market is further
bifurcated into Ebola, SARS-COV, MERS-COV, COVID-19. Ebola is anticipated to
hold the largest revenue shares of the market and assert its dominance over the
market segment in the upcoming five years, on the account of surge in
infections caused due to the virus. COVID-19 is anticipated to register the fastest
growing CAGR growth in the upcoming five years. The pandemic caused due to
outbreak of viral infection has surged the number of patients to multiple
folds. Moreover, the country is still under the threat of new variant of the
virus that is continuously claiming lives and the drug Remdesivir is expected
to help with the treatment, and thus supports the growth of the India
Remdesivir market in the next five years.
Some of the top players in
the India Remdesivir Market are, Cipla Ltd., Hetero Labs Pvt. Ltd., Jubilant
Life Sciences Ltd., Viatris Pharmaceuticals Ltd. (Mylan Laboratories India Pvt.
Ltd.), Dr. Reddy’s Laboratories Ltd., Sun Pharmaceuticals Industries Ltd., Zydus
Cadila Healthcare Ltd., Pfizer Ltd., Gilead Sciences India Private Limited, Eva
Pharma Pvt. Ltd., among others. The companies are involving themselves into
research and development for more advanced form of the drug. Remdesivir is the
therapeutic drug against the coronavirus, COVID-19 and are in demand owing to
the need of the healthcare industry in the country. Although the export of the
drug is increasing rapidly to satisfy the consumer demand. New players entering
the market may form partnerships with other players or the end users of the
industry for a consistent inflow of the product.
for this report:
Historical Years: FY2017 – FY2020
Base Year: FY2021
Estimated Year: FY2022
Forecast Period: FY2023 – FY2027
Objective of the Study:
- To analyze the historical
growth of the market size of India Remdesivir market from FY2017 to FY2020.
- To estimate and forecast the market size of India Remdesivir
market from FY2021 to FY2027 and growth rate until FY2027.
- To classify and forecast India Remdesivir market based on application, route of administration, dosage form,
patient age, distribution channel, competitional landscape, and regional
- To identify dominant region or segment in the
India Remdesivir market.
- To identify drivers and challenges for India Remdesivir
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in
India Remdesivir market.
- To identify and analyze
the profile of leading players operating in India Remdesivir market.
- To identify key sustainable strategies adopted
by market players in India Remdesivir market.
Click here to download the sample
TechSci Research performed both primary
as well as exhaustive secondary research for this study. Initially, TechSci
Research sourced a list of manufacturers, suppliers, and service providers
across the country. Subsequently, TechSci Research conducted primary research
surveys with the identified companies. While interviewing, the respondents were
also enquired about their competitors. Through this technique, TechSci Research
could include the manufactures which could not be identified due to the
limitations of secondary research. TechSci Research analyzed the manufactures,
distribution channels and presence of all major players across the country.
TechSci Research calculated the market
size of India Remdesivir
market using a bottom-up
approach, wherein data for various end-user segments was recorded and forecast
for the future years. TechSci Research sourced these values from the industry
experts and company representatives and externally validated through analyzing
historical data of these product types and applications for getting an
appropriate, overall market size. Various secondary sources such as company
websites, news articles, press releases, company annual reports, investor
presentations and financial reports were also studied by TechSci Research.
- Remdesivir manufacturers, end users, and other
- Distributers and suppliers of Remdesivir and other
- Organizations, forums and alliances related to coronavirus
- Market research and consulting firms
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers, end users, etc., besides allowing them in
strategizing investments and capitalizing on market opportunities.
In this report, India Remdesivir market has been segmented into
following categories, in addition to the industry trends which have also been
- India Remdesivir Market, By Application:
- India Remdesivir Market, By Route
- India Remdesivir Market, By Dosage
o Frozen Solution
o Lypholized Solution
- India Remdesivir Market, By Patient
- Pediatric (12 years or older)
- India Remdesivir Market, By Distribution
- Drug Stores/Pharmacies
- India Remdesivir Market, By Region:
analysis of the major companies present in India Remdesivir market.
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
India Remdesivir Market is
an upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]
- Detailed analysis and profiling of additional market players (up to